Immunic Inc (IMUX): More upward price movement. Up 10% in tw...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Immunic Inc (IMUX)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	41
Posts	552
Boards Moderated	0
Alias Born	03/27/2014

Re: None

Monday, 07/07/2025 10:54:37 AM

Monday, July 07, 2025 10:54:37 AM

More upward price movement. Up 10% in two trading days.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IMUX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 11:00:48 AM
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors • PR Newswire (US) • 05/19/2026 10:30:00 AM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:34:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:01:04 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 10:36:56 AM
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 10:30:00 AM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/06/2026 10:01:51 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:15:46 PM
Immunic to Participate in Investor and Medical Conferences in May • PR Newswire (US) • 04/30/2026 10:30:00 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 11:12:20 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:00:28 AM
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer • PR Newswire (US) • 04/28/2026 10:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:30:43 PM
Immunic, Inc. Announces 1-for-10 Reverse Stock Split • PR Newswire (US) • 04/23/2026 12:00:00 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/22/2026 08:56:18 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/17/2026 02:13:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:05:25 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/09/2026 08:30:55 PM
Immunic to Participate in Scientific and Medical Conferences in April • PR Newswire (US) • 04/09/2026 10:30:00 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 08:31:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 11:00:32 AM
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 04/01/2026 10:30:00 AM

More IMUX News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow